Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Beata Mierzwa: Bridging the divide between science and art.

Infarinato N.

J Cell Biol. 2018 Dec 3;217(12):4051-4052. doi: 10.1083/jcb.201811004. Epub 2018 Nov 14.

PMID:
30429211
2.

BethAnn McLaughlin: Protecting neurons and women in science.

Infarinato N, O'Donnell MA.

J Cell Biol. 2018 Nov 5;217(11):3769-3771. doi: 10.1083/jcb.201810065. Epub 2018 Oct 23.

PMID:
30352946
3.

Dan Davis: Up close and personal with immune cells.

Infarinato N.

J Cell Biol. 2018 Sep 3;217(9):2975-2976. doi: 10.1083/jcb.201808060. Epub 2018 Aug 14.

PMID:
30108126
4.

Jerry Edward Chipuk: A powerhouse for mitochondrial biology.

O'Donnell MA, Infarinato N.

J Cell Biol. 2018 Aug 6;217(8):2599-2600. doi: 10.1083/jcb.201807034. Epub 2018 Jul 10.

PMID:
29991520
5.

Johan Auwerx: Sowing the seeds of translational research.

Infarinato N.

J Cell Biol. 2018 May 7;217(5):1557-1558. doi: 10.1083/jcb.201804083. Epub 2018 Apr 25.

6.

Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma.

Wood AC, Krytska K, Ryles HT, Infarinato NR, Sano R, Hansel TD, Hart LS, King FJ, Smith TR, Ainscow E, Grandinetti KB, Tuntland T, Kim S, Caponigro G, He YQ, Krupa S, Li N, Harris JL, Mossé YP.

Clin Cancer Res. 2017 Jun 1;23(11):2856-2868. doi: 10.1158/1078-0432.CCR-16-1114. Epub 2016 Dec 16.

7.

The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma.

Infarinato NR, Park JH, Krytska K, Ryles HT, Sano R, Szigety KM, Li Y, Zou HY, Lee NV, Smeal T, Lemmon MA, Mossé YP.

Cancer Discov. 2016 Jan;6(1):96-107. doi: 10.1158/2159-8290.CD-15-1056. Epub 2015 Nov 10.

8.

Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma.

Krytska K, Ryles HT, Sano R, Raman P, Infarinato NR, Hansel TD, Makena MR, Song MM, Reynolds CP, Mossé YP.

Clin Cancer Res. 2016 Feb 15;22(4):948-60. doi: 10.1158/1078-0432.CCR-15-0379. Epub 2015 Oct 5.

Supplemental Content

Loading ...
Support Center